5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.58▼ | 3.62▼ | 3.60▼ | 3.60▼ | 3.95▼ |
MA10 | 3.58▼ | 3.60▼ | 3.62▼ | 3.84▼ | 3.31▲ |
MA20 | 3.61▼ | 3.63▼ | 3.67▼ | 4.02▼ | 2.38▲ |
MA50 | 3.61▼ | 3.62▼ | 3.65▼ | 3.28▲ | 2.84▲ |
MA100 | 3.62▼ | 3.69▼ | 3.86▼ | 2.37▲ | 4.82▼ |
MA200 | 3.67▼ | 3.89▼ | 4.12▼ | 2.66▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.005▼ | -0.006▼ | -0.122▼ | 0.277▲ |
RSI | 39.173▼ | 42.027▼ | 43.475▼ | 46.929▼ | 57.922▲ |
STOCH | 25.833 | 54.777 | 31.335 | 18.159▼ | 72.170 |
WILL %R | -93.750▼ | -78.947▼ | -84.000▼ | -84.000▼ | -39.409 |
CCI | -74.716 | -69.626 | -110.550▼ | -76.320 | 47.352 |
Thursday, August 07, 2025 04:47 PM
Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.
|
Thursday, August 07, 2025 09:45 AM
Berkshire Hathaway has resumed acquiring shares of Warren Buffett's favorite media stock. Other insider buyers are focused on three biotech stocks.
|
Thursday, August 07, 2025 09:27 AM
Key Points Prime Medicine posted GAAP revenue of $1.1 million, missing analyst expectations by over 70% (GAAP). Reported net loss (GAAP) narrowed to $52.6 million, driven by reduced research and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 3.64 | 3.72 | 3.53 | 3.57 | 3,665,101 |
14/08/25 | 3.66 | 3.778 | 3.5802 | 3.64 | 2,377,764 |
13/08/25 | 3.50 | 3.88 | 3.47 | 3.81 | 3,192,067 |
12/08/25 | 3.60 | 3.69 | 3.35 | 3.46 | 4,899,178 |
11/08/25 | 3.88 | 3.88 | 3.46 | 3.51 | 4,745,165 |
08/08/25 | 3.67 | 3.79 | 3.50 | 3.785 | 3,590,821 |
07/08/25 | 4.04 | 4.138 | 3.61 | 3.68 | 6,621,088 |
06/08/25 | 4.30 | 4.36 | 4.01 | 4.07 | 3,850,647 |
05/08/25 | 4.46 | 4.4964 | 4.135 | 4.37 | 4,070,903 |
04/08/25 | 4.35 | 4.725 | 4.2407 | 4.50 | 5,601,478 |
|
|
||||
|
|
||||
|
|